SCHEMBL23372690

SCHEMBL23372690

c1ccc2sc(-c3cc(Nc4ccc5oc6ccccc6c5c4)cc4c3oc3ccccc34)nc2c1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPT P10636 7/20 0.48
▸ SMN1; SMN2 Q16637 3/20 0.48
▸ HPGD P15428 2/20 0.48
▸ EGFR P00533 6/20 0.43
▸ KDR P35968 4/20 0.42
▸ AURKB Q96GD4 2/20 0.42
▸ MEN1 O00255 7/20 0.42
▸ KMT2A Q03164 7/20 0.42
▸ ALDH1A1 P00352 4/20 0.42
▸ IGF1R P08069 3/20 0.42
▸ POLB P06746 2/20 0.42
▸ L3MBTL1 Q9Y468 2/20 0.42
▸ SRC P12931 2/20 0.42
▸ EPHB4 P54760 1/20 0.42
▸ KDM4E B2RXH2 4/20 0.41
▸ RAB9A P51151 3/20 0.41
▸ THRB P10828 1/20 0.41
▸ CTDSP1 Q9GZU7 1/20 0.41
▸ TEK Q02763 3/20 0.40
▸ FLT4 P35916 2/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24156101 0.85 MAPT (0.48) MAPTSMN1; SMN2HPGDEGFRKDR
SCHEMBL24155785 0.77 FLT4 (0.56) MAPTSMN1; SMN2HPGDEGFRKDR
SCHEMBL22796217 0.77 APP (0.50) MAPTSMN1; SMN2HPGDEGFRKDR
SCHEMBL8964766 0.75 MAPT (0.56) MAPTSMN1; SMN2HPGDMEN1KMT2A
SCHEMBL30883931 0.74 MEN1 (0.52) MAPTSMN1; SMN2HPGDEGFRKDR
SCHEMBL26100051 0.74 MEN1 (0.52) MAPTSMN1; SMN2HPGDEGFRKDR
SCHEMBL23382847 0.74 RIPK2 (0.44) EGFRKDR
SCHEMBL25636279 0.73 PTGIR (0.41) MAPTHPGDMEN1KMT2AALDH1A1
SCHEMBL25012052 0.72 MEN1 (0.53) MAPTSMN1; SMN2HPGDMEN1KMT2A
SCHEMBL2785067 0.72 MAPT (0.57) MAPTSMN1; SMN2HPGDMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4269406-B1 COMPOUND FOR ORGANIC ELECTRICAL ELEMENT, ORGANIC ELECTRICAL ELEMENT USING SAME AND ELECTRONIC DEVICE THEREOF DUK SAN NEOLUX CO LTD (KR) 2024-07-10 — — EP disclosed
US-11563182-B2 Compound for organic electronic element, organic electronic element using the same, and an electronic device thereof DUK SAN NEOLUX CO., LTD. (KR) 2023-01-24 — — US disclosed
US-20220376185-A1 COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC ELEMENT USING THE SAME, AND AN ELECTRONIC DEVICE THEREOF DUK SAN NEOLUX CO., LTD. (KR) 2022-11-24 — — US disclosed
US-11072603-B2 Compound for organic electronic element, organic electronic element using the same, and an electronic device thereof DUK SAN NEOLUX CO., LTD. (KR) 2021-07-27 — — US disclosed
US-11072604-B2 Compound for organic electronic element, organic electronic element using the same, and an electronic device thereof DUK SAN NEOLUX CO., LTD. (KR) 2021-07-27 — — US disclosed
US-20210147396-A1 COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC ELEMENT USING THE SAME, AND AN ELECTRONIC DEVICE THEREOF DUK SAN NEOLUX CO., LTD. (KR) 2021-05-20 — — US disclosed
US-20210147397-A1 COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC ELEMENT USING THE SAME, AND AN ELECTRONIC DEVICE THEREOF DUK SAN NEOLUX CO., LTD. (KR) 2021-05-20 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11072603-B2 Compound for organic electronic element, organic electronic element using the same, and an electronic device thereof ETV6, OR51E2, NFE2L2 MAPT 1315/4885SMN1; SMN2 917/4885HPGD 3744/4885
US-20210147397-A1 COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC ELEMENT USING THE SAME, AND AN ELECTRONIC DEVICE THEREOF ETV6, OR51E2, NFE2L2 MAPT 1315/4885SMN1; SMN2 917/4885HPGD 3744/4885
US-20210147396-A1 COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC ELEMENT USING THE SAME, AND AN ELECTRONIC DEVICE THEREOF ETV6, OR51E2, NFE2L2 MAPT 1315/4885SMN1; SMN2 917/4885HPGD 3744/4885
US-20220376185-A1 COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC ELEMENT USING THE SAME, AND AN ELECTRONIC DEVICE THEREOF TCF7, MCM7, LUC7L2 MAPT 2068/4885SMN1; SMN2 1262/4885HPGD 3501/4885
US-11563182-B2 Compound for organic electronic element, organic electronic element using the same, and an electronic device thereof TCF7, MCM7, LUC7L2 MAPT 2068/4885SMN1; SMN2 1262/4885HPGD 3501/4885
US-11072604-B2 Compound for organic electronic element, organic electronic element using the same, and an electronic device thereof ETV6, OR51E2, NFE2L2 MAPT 1315/4885SMN1; SMN2 917/4885HPGD 3744/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback